# LANDMARK Trial: a Randomised Controlled Trial of Myval THV

Study · id `cardio:ct-nct04275726` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04275726](<https://clinicaltrials.gov/study/NCT04275726>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04275726

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 988 participants.

## Technical summary

Registry record NCT04275726. Randomized; no masking; primary purpose treatment. Start 2020-11-04 (actual); primary completion 2024-03-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 988 participants (planned count; ClinicalTrials.gov record NCT04275726, source copy `cardio:ctgov-nct04275726-2026-08-17`, retrieved 2026-11-18)
- Started: 2020-11-04 (actual) (ClinicalTrials.gov record NCT04275726, source copy `cardio:ctgov-nct04275726-2026-08-17`, retrieved 2026-11-18)
- Primary completion: 2024-03-07 (actual) (ClinicalTrials.gov record NCT04275726, source copy `cardio:ctgov-nct04275726-2026-08-17`, retrieved 2026-11-18)
- Completion: 2033-12-31 (anticipated) (ClinicalTrials.gov record NCT04275726, source copy `cardio:ctgov-nct04275726-2026-08-17`, retrieved 2026-11-18)
- Countries: Belarus; Brazil; Croatia; Estonia; France; Germany; Greece; Hungary; Italy; Netherlands; New Zealand; Poland; Portugal; Slovakia; Slovenia; Spain; Sweden (ClinicalTrials.gov record NCT04275726, source copy `cardio:ctgov-nct04275726-2026-08-17`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04275726-2026-08-17`, retrieved 2026-11-18)

## The registry's words

- Brief title: LANDMARK Trial: a Randomised Controlled Trial of Myval THV
- Acronym: LANDMARK
- Condition: Aortic Valve Stenosis
- Intervention (Device): Myval THV Series
- Intervention (Device): Contemporary Valves (Sapien THV Series and Evolut THV Series)
- Lead sponsor: Meril Life Sciences Pvt. Ltd.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Meril Life Sciences Pvt. Ltd. (`cardio:org-meril-life-sciences-pvt-ltd`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial (`cardio:pubmed-38795719`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosis (`cardio:pubmed-39589296`)
- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: 1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: The LANDMARK Trial (`cardio:pubmed-41384893`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparative 30-day echocardiographic outcomes of Myval vs. Sapien and Evolut THVs: insights from LANDMARK trial (`cardio:pubmed-40875489`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Cardiac Damage and Clinical Outcomes in Symptomatic Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement (`cardio:pubmed-43003595`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: eb4a1168416f139b9e597d7943e2b70b8b94c1c67161dc1c7c157812b6e88b40
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
